rs80357024
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BS1BS3BP1_Strong
This summary comes from the ClinGen Evidence Repository: The c.1233T>G variant in BRCA1 is a missense variant predicted to cause substitution of Aspartic acid by Glutamic acid at amino acid 411 (p.Asp411Glu). The highest non-cancer, non-founder population filter allele frequency in gnomAD v2.1 (exomes only, non-cancer subset, read depth ≥20) or gnomAD v3.1 (non-cancer subset, read depth ≥20) is 0.0002413 in the African/African American population, which is above the ENIGMA BRCA1/2 VCEP threshold (>0.0001) for BS1, and below the BA1 threshold (>0.001) (BS1 met). This missense variant is located outside of a key functional domain and was not predicted to alter mRNA splicing using the SpliceAI predictor (score 0.07, score threshold <0.1) (BP1_Strong met). Reported by one calibrated study to exhibit protein function similar to benign control variants (PMID:32546644) (BS3 met).In summary, this variant meets the criteria to be classified as a Benign variant for BRCA1-related cancer predisposition based on the ACMG/AMP criteria applied as specified by the ENIGMA BRCA1/2 VCEP (BS1, BP1_Strong, BS3). LINK:https://erepo.genome.network/evrepo/ui/classification/CA000811/MONDO:0011450/092
Frequency
Consequence
NM_007294.4 missense
Scores
Clinical Significance
Conservation
Publications
- BRCA1-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- breast-ovarian cancer, familial, susceptibility to, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- Fanconi anemia, complementation group SInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- pancreatic cancer, susceptibility to, 4Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- hereditary breast ovarian cancer syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BRCA1 | MANE Select | c.1233T>G | p.Asp411Glu | missense | Exon 10 of 23 | NP_009225.1 | P38398-1 | ||
| BRCA1 | c.1233T>G | p.Asp411Glu | missense | Exon 10 of 24 | NP_001394510.1 | A0A2R8Y7V5 | |||
| BRCA1 | c.1233T>G | p.Asp411Glu | missense | Exon 10 of 24 | NP_001394511.1 | A0A2R8Y7V5 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BRCA1 | TSL:1 MANE Select | c.1233T>G | p.Asp411Glu | missense | Exon 10 of 23 | ENSP00000350283.3 | P38398-1 | ||
| BRCA1 | TSL:1 | c.1233T>G | p.Asp411Glu | missense | Exon 10 of 24 | ENSP00000418960.2 | P38398-7 | ||
| BRCA1 | TSL:1 | c.1233T>G | p.Asp411Glu | missense | Exon 10 of 23 | ENSP00000419274.2 | P38398-1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152250Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000359 AC: 9AN: 250816 AF XY: 0.0000369 show subpopulations
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461846Hom.: 0 Cov.: 34 AF XY: 0.0000110 AC XY: 8AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000125 AC: 19AN: 152368Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74520 show subpopulations
Age Distribution
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at